Pierre d’Epenoux is the founder of ImCheck Therapeutics. ImCheck Therapeutics has raised $150M in total funding. Latest round: Series C.
Pierre d’Epenoux is a biotech executive and board member who served as CEO of ImCheck Therapeutics, a Marseille-based immuno-oncology company. He led the company through clinical development, raised three funding rounds totaling $150 million, and oversaw its acquisition by Ipsen. As of 2026, he also holds an independent chairmanship role at Elkedonia.
Full founder directory · Investor directory · Company funding database · Fundraising library